{"componentChunkName":"component---src-templates-news-news-template-tsx","path":"/news/weekly-news-of-life-science-area-22092020","result":{"pageContext":{"article":{"id":101,"title":"Weekly news of Life Science Área! 22/09/2020","slug":"weekly-news-of-life-science-area-22092020","article":"<p style=\"text-align: left;\"><strong>News 09/22/2020</strong></p><p style=\"text-align: left;\"><a href=\"tps://www.istoedinheiro.com.br/covid-19-biontech-compra-laboratorio-da-novartis-para-elevar-producao-de-vacina-2/\" target=\"_blank\"><strong><span style=\"font-size: 18px;\">BioNTech buys Novartis lab to boost vaccine production.</span></strong></a></p><p style=\"text-align: left;\"><a href=\"tps://www.istoedinheiro.com.br/covid-19-biontech-compra-laboratorio-da-novartis-para-elevar-producao-de-vacina-2/\" target=\"_blank\"> The German BioNTech,which produces a potential vaccine against Covid-19 with the American Pfizer,said in a statement on Thursday (17) that signed the purchase of a laboratoryof Novartis, pharmaceutical company. The acquisition, according to BioNTech,will serve for the biotechnology company to expand vaccine production to atotal of 750 million doses per year.</a></p><p style=\"text-align: left;\"><br></p><p style=\"text-align: left;\"><a href=\"https://www.in.gov.br/en/web/dou/-/instrucao-normativa-n-94-de-18-de-setembro-de-2020-278692811\" target=\"_blank\"><strong><span style=\"font-size: 18px;\">MAPA approves the technical regulation that sets the Identity and Quality Standards for Whey and Whey Acid.</span></strong> </a></p><p style=\"text-align: left;\"><a href=\"https://www.in.gov.br/en/web/dou/-/instrucao-normativa-n-94-de-18-de-setembro-de-2020-278692811\" target=\"_blank\">The standards of identity and quality that must meet whey and sour whey are of liquid,concentrated and powdered forms, intended for human consumption.</a></p><p style=\"text-align: left;\"><a href=\"https://www.in.gov.br/en/web/dou/-/instrucao-normativa-n-94-de-18-de-setembro-de-2020-278692811\" target=\"_blank\"><br></a></p><p style=\"text-align: left;\"><strong style=\"font-size: 1rem;\"><span style=\"font-size: 18px;\"><a href=\"https://sindusfarma.org.br/uploads/file%20-%20Copy%2089.pdf\" target=\"_blank\">Amended the temporary resolution RDC No. 350 of March 2020 for the production of sanitizers in extraordinary condition due to Covid.</a></span></strong></p><p style=\"text-align: left;\"><span style=\"font-size: 16px;\"><span style=\"font-size: 16px;\"><a href=\"https://sindusfarma.org.br/uploads/file%20-%20Copy%2089.pdf\" target=\"_blank\" style=\"\"></a></span><span style=\"font-size: 18px;\"><a href=\"https://sindusfarma.org.br/uploads/file%20-%20Copy%2089.pdf\" target=\"_blank\" style=\"\"><span style=\"font-size: 16px;\"> Farmaceutical, sanitizers and cosmetic sanitizers companies may manufacture antiseptic preparations or disinfectants without registration or notification with Anvisa provided that the criteria set out in the new resolution are met.</span></a></span></span></p><p style=\"text-align: left;\"><span style=\"font-size: 16px;\"><span style=\"font-size: 18px;\"><a href=\"https://sindusfarma.org.br/uploads/file%20-%20Copy%2089.pdf\" target=\"_blank\" style=\"\"></a></span><span style=\"font-size: 18px;\"><a href=\"https://sindusfarma.org.br/uploads/file%20-%20Copy%2089.pdf\" target=\"_blank\" style=\"\"></a></span></span></p><p style=\"text-align: left;\"><a href=\"https://sindusfarma.org.br/uploads/file%20-%20Copy%2090.pdf\" target=\"_blank\"><strong><span style=\"font-size: 18px;\">Anvisa chages RDC no. 27,36,40 to provide for the extinction of the registration and migration regime of risk class II medical devices to the notification regime.</span></strong> </a></p><p style=\"text-align: left;\"><a href=\"https://sindusfarma.org.br/uploads/file%20-%20Copy%2090.pdf\" target=\"_blank\">The resolution has the objective of defining the requirements of the notification regime for the sanitary control of medical products of risk classes I and II, exempted from registration in the form of §1 of Article 25 of Law No. 6,360 of 1976.\"(NR)</a></p><p style=\"text-align: left;\"><br></p><p style=\"text-align: left;\"><strong><span style=\"font-size: 18px;\"><a href=\"https://www.kivalitaconsulting.com/news/semana-da-qualidade\" target=\"_blank\">Kivalita Consultingmakes on Tuesday (22) Webinar on ISO 27.001 and its applications </a></span></strong></p><p style=\"text-align: left;\"><span style=\"font-size: 16px;\"><span style=\"font-size: 16px;\"><a href=\"https://www.kivalitaconsulting.com/news/semana-da-qualidade\" target=\"_blank\" style=\"\"></a></span><span style=\"font-size: 18px;\"><a href=\"https://www.kivalitaconsulting.com/news/semana-da-qualidade\" target=\"_blank\" style=\"\"><span style=\"font-size: 16px;\">The webinar is partof Quality Week, and there will be a step-by-step checklist of the applicationof an ISO 27.001 exclusive to online participants at 7:30 pm today.</span></a></span></span><span style=\"font-size: 18px;\"><a href=\"https://www.kivalitaconsulting.com/news/semana-da-qualidade\" target=\"_blank\" style=\"\"></a></span></p><p style=\"text-align: left;\"><strong>Sign Up now in our newsletter to have all of it in you e-mail by morning!</strong></p>","published":true,"createdAt":"2020-09-22T13:55:56.6182951","imageId":199,"postImage":{"id":199,"type":"Blog","fileName":"d5ffe3fc-d4c5-469b-8a38-aa59615675e9.jpg","imageData":null,"imageUrl":"https://kivalitaapi.azurewebsites.net/resources/images/d5ffe3fc-d4c5-469b-8a38-aa59615675e9.jpg","url":null,"imageString":null},"authorId":13,"imageData":null,"language":0,"isNews":true,"isLegislation":false,"linkId":100,"translateSlug":"noticias-semanais-sobre-life-science-22092020"}}},"staticQueryHashes":["4202924991"]}